Psychedelic Spotlight: The Psychedelics Industry in 2022 Was a Wild Ride
Originally appearing here (Archived)
MAPS in the Media
The Dales Report: Potential For MDMA-Assisted Therapy Approval Boosts Psychedelic Stocks Early In 2023
Originally appearing here (Archived)
Green Market Report: Congress Hops on Psychedelics Juggernaut with a New Caucus
Originally appearing here (Archived)
BBC Sounds: MDMA for PTSD
Originally appearing here (Archived)
Vice: ‘This Is Our Protest:’ Black People Are Taking Shrooms to Heal From Racism
Originally appearing here (Archived)
Awakn Life Sciences: What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector’s Performance & Takeaways
Originally appearing here (Archived)
The Economist: The World Ahead 2023: Five Stories to Watch Out For
Summary: “2023 could potentially be a landmark year for us. This could be the first psychedelic-assisted therapy approved by a regulatory body,” says Amy Emerson, CEO of MAPS Public Benefit …
The Guardian: What Will Happen in 2023? A Calendar of the Year
Originally appearing here (Archived)
MarketScreener: Optimi Health: Year-End Letter to Shareholders
Originally appearing here (Archived)
The World Ahead 2023: five stories to watch out for – The Economist
FilterMag: The Cannabis and Psychedelics Reforms to Watch For in 2023
Originally appearing here (Archived)
NBC News: Psychedelic Therapies are On the Horizon, But Who Will Administer the Drugs?
Summary: NBCNews examines what it takes to prepare the next generation of psychedelic therapists, highlighting the wide variety of universities and schools making an increasing effort to train the therapists …